New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy

• June 9, 2026
• HealthDayTV HealthDay Reporter

Researchers found no substantial increase in the risk of pregnancy loss, abnormal fetal growth, or major congenital malformations among pregnancies with first-trimester GLP-1 exposure. But they say more studies are needed.

Health News is provided as a service to Atlantic Pharmacy site users by HealthDay. Atlantic Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2026 HealthDay All Rights Reserved.

Tags